BiopharmaTrend: Where Tech Meets Bio

BioPharmaTrend

AI report cover

Latest News

Axiom Bio Launches with $15M to Replace …

Axiom Bio Launches with $15M to Replace Animal Testing with AI for Drug Toxicity Prediction

San Francisco-based startup founded by Brandon White and Alex Beatson has announced $15 million in seed funding from Amplify Partners, Dimension Capital, and Zetta Ventures, … Read More

Raidium Publishes Promptable CT Foundation Model for …

Raidium Publishes Promptable CT Foundation Model for Tumor Segmentation

Raidium, a Paris-based medical AI company founded in 2022 by radiologist Dr. Paul Hérent and data scientist Pierre Manceron, focuses on developing multimodal foundation models … Read More

Tempus Introduces Loop, an AI-Driven Platform for …

Tempus Introduces Loop, an AI-Driven Platform for Target Discovery and Validation

Tempus AI, Inc. (NASDAQ: TEM) announced the launch of Tempus Loop, a proprietary oncology-focused platform designed to streamline target discovery and validation by integrating real-world … Read More

NHS Wales Pilots Paige AI Tool to Triage Cancer Cases

Immunai and Parker Institute to Build Largest Single-Cell Dataset for Real-World Immunotherapy Research

Potato Lands $4.5M to Automate Lab Work with AI and Robots

Tempus, AstraZeneca, and Pathos Partner to Build Oncology Foundation Model Using Multimodal Data

GeneDx to Acquire Fabric Genomics to Enable AI-Powered, Decentralized Genome Interpretation

Elix and PRISM BioLab Partner to Tackle Hard-to-Drug Protein Targets with AI

Read latest news ›››

Latest Insights

Combination Therapies May Be the Future of …

by Andreas Dreps, Bea Mann, PhD

Combination Therapies May Be the Future of Oncology – How Can We Navigate Development Challenges Today?

The field of oncology is experiencing a proliferation of cancer therapies. In 2024 alone, the U.S. Food and Drug Administration (FDA) issued more than 60 … Read More

Chemistry CROs at a Crossroads: How SpiroChem …

by Thomas Fessard

Chemistry CROs at a Crossroads: How SpiroChem Is Adapting to Market Shifts in 2025 and Beyond

As we approach 2025, the role of chemistry Contract Research Organizations (CROs) is undergoing profound transformation. Chemistry is no longer considered a commodity but an … Read More

Novotech Report: Over 800 Global IPF Trials Since 2020, Led by Asia-Pacific

by BiopharmaTrend

Report: Nearly 80% of Life Sciences Leaders Considering Virtual Models for Observational Research

by BiopharmaTrend

AI in Drug Safety: From Concept to Reality, The Industry's Path Forward

by Dr. Karthik Muthusamy

Marking the Path Ahead: Integrating Oncology Biomarkers Into Clinical Development

by Bea Mann, PhD

Combination Therapies May Be the Future of Oncology – How Can We Navigate Development Challenges Today?

by Andreas Dreps, Bea Mann, PhD

The Future of Advanced Therapeutics: Opportunities and Challenges

by Sai Bhamidipati

What CROs Cite as Their Top Clinical Trial Challenges and How They Plan to Overcome Them in 2025

by Megan Deegan

21 Life Science Marketplaces to Try in 2024

by Andrii Buvailo

Read all insights ›››

From Our Partners

Read All ›››

Beyond Traditional Clinical Trials: MEDSIR’s Adaptive Designs …

Sponsored by MEDSIR

Beyond Traditional Clinical Trials: MEDSIR’s Adaptive Designs and Precision Medicine in Oncology

Navigating the Crossroads of AI and Oncology: …

Sponsored by Lantern Pharma

Navigating the Crossroads of AI and Oncology: A Deep Dive with Lantern Pharma's CEO, Panna Sharma

Chemistry CROs at a Crossroads: How SpiroChem …

Sponsored by SpiroChem

Chemistry CROs at a Crossroads: How SpiroChem Is Adapting to Market Shifts in 2025 and Beyond

Unlocking Interoperability with AI: How This Company …

Sponsored by Trialize

Unlocking Interoperability with AI: How This Company is Building a New Framework for Clinical Trials

Partner Events

View all events ›››

London Biotechnology Show 2025

London Biotechnology Show 2025

Event Date: June 18, 2025 - June 19, 2025

Location: United Kingdom (Hall N7 & N8 Bett Global, Excel London, Royal Victoria Dock, 1 Western Gateway, London, UK, England, GB, E16 1XL)

Website: Link

Global Clinical Trials Connect 2025

Global Clinical Trials Connect 2025

Event Date: May 28, 2025 - May 29, 2025

Location: United Kingdom (London)

Website: Link

22nd BioPharma Drug Discovery Nexus Conference Belgium

22nd BioPharma Drug Discovery Nexus Conference Belgium

Event Date: April 29, 2026 - April 29, 2026

Location: Belgium (Brussels, Holiday Inn)

Website: Link

The 12th Aging Research & Drug Discovery Meeting The 11th Aging Research & Drug Discovery Meeting

The 12th Aging Research & Drug Discovery Meeting The 11th Aging Research & Drug Discovery Meeting

Event Date: Aug. 25, 2025 - Aug. 29, 2025

Location: Denmark (Ceremonial Hall, University of Copenhagen)

Website: Link

Case Studies

Read All ›››

Powering Cancer Drug Discovery and Development Using …

Sponsored by Lantern Pharma

Powering Cancer Drug Discovery and Development Using the Artificial Intelligence and Machine Learning Platform RADR®

How Astellas Pharma Achieves R&D Operational Excellence …

Sponsored by Science Exchange

How Astellas Pharma Achieves R&D Operational Excellence with Science Exchange

Biocompare: Offline Order Attribution Analysis Helps Demonstrate …

Sponsored by Biocompare

Biocompare: Offline Order Attribution Analysis Helps Demonstrate Marketing Effectiveness

Identifying High Impact Tissue Sparing E3 Ligases …

Sponsored by Kymera Therapeutics

Identifying High Impact Tissue Sparing E3 Ligases and Their Binders

Busting the PoseBusters v3: AI Docking Software …

Sponsored by RECEPTOR.AI

Busting the PoseBusters v3: AI Docking Software ArtiDock Beats Industry’s State of the Art in Speed and Accuracy

Cyclica's Chemical Probes for DCAF1

Sponsored by Cyclica

Cyclica's Chemical Probes for DCAF1

Revolutionizing Clinical Trials: How AI and Automation …

Sponsored by Trialize

Revolutionizing Clinical Trials: How AI and Automation Reduced Study Build Time from Months to Days

QUAISAR Computational Platform for Designing Targeted Protein …

Sponsored by Roivant Sciences

QUAISAR Computational Platform for Designing Targeted Protein Degraders

Interviews

Read All ›››

Democratizing Early Drug Discovery through Artificial Intelligence: …

Democratizing Early Drug Discovery through Artificial Intelligence: Interview with Syntekabio CEO Jongsun Jung

Rethinking Clinical Trials: Tim Smith on Medable’s …

Rethinking Clinical Trials: Tim Smith on Medable’s Approach to Speed and Efficiency

[Interview] How D-Wave Brings Quantum Computing Into …

[Interview] How D-Wave Brings Quantum Computing Into Biology

Navigating the Crossroads of AI and Oncology: …

Navigating the Crossroads of AI and Oncology: A Deep Dive with Lantern Pharma's CEO, Panna Sharma

Most Read

Playing Chess Against Cancer: A Pharmaceutical, Biotechnological, …

Playing Chess Against Cancer: A Pharmaceutical, Biotechnological, and Clinical Guide to Modern Day Oncologic Treatment Cartography

14 Companies Using Quantum Theory To Accelerate …

14 Companies Using Quantum Theory To Accelerate Drug Discovery (Including 2 Going Public)

5 AI-Powered Companies Transforming the Future of …

5 AI-Powered Companies Transforming the Future of Fertility Care

10 Companies Applying AI for Biologics Discovery

10 Companies Applying AI for Biologics Discovery